An examination of the effect of combined cyclical hormone replacement therapy on lipoprotein(a) and other lipoproteins
- 26 January 1996
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 119 (2) , 215-222
- https://doi.org/10.1016/0021-9150(95)05650-5
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Lipoprotein(a) in patients with carotid atherosclerosis and ischemic cerebrovascular disordersAtherosclerosis, 1993
- Lipoprotein Lp(a) levels are reduced by danazol, an anabolic steroidAtherosclerosis, 1992
- Effects of Postmenopausal Estrogen Replacement on the Concentrations and Metabolism of Plasma LipoproteinsNew England Journal of Medicine, 1991
- Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidencePreventive Medicine, 1991
- Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men.BMJ, 1990
- Effects of post-menopausal oestrogen-progestogen replacement therapy on serum lipids and lipoproteins: a reviewMaturitas, 1990
- Metabolic regulation of apoproteins of high-density lipoproteins by estrogen and progesterone in the baboon (Papio sp)Metabolism, 1990
- Continuous estrogen/progestin therapy in menopauseAmerican Journal of Obstetrics and Gynecology, 1987
- Clinical and lipid metabolic effects of unopposed oestrogen and two oestrogen-progestogen regimens in post-menopausal womenMaturitas, 1987
- Subfractions of high-density lipoprotein cholesterol during estrogen replacement therapy: A comparison between progestogens and natural progesteroneAmerican Journal of Obstetrics and Gynecology, 1985